Statins and C-reactive protein: considering a novel marker of cardiovascular risk.


Landmark intervention trials have validated the importance of lipid control in reducing the incidence of coronary ischemic events, over a range of baseline lipid levels. With the release of the third iteration of the National Cholesterol Education Programs Adult Treatment Panel guidelines, there is renewed debate about the appropriate use of pharmacologic… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics